Desflurane versus Sevoflurane in cirrhotic patients undergoing liver resection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201404000804408

Enrollment

Registered

2014-03-31

Start date

2013-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Digestive System Surgery Patients undergoing liver transplantation

Interventions

Desflurane group

Sevoflurane

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients Child A cirrhotic patient.

Exclusion criteria

Exclusion criteria: Oesophageal disease Re-operation. History of allergic reaction to drugs used. Recent anaesthesia (within 7 days). Severe bleeding intra-operatively and Haemodynamic unstability. Preoperative renal dysfunction.

Design outcomes

Primary

Measure	Time frame
Liver function tests	—

Secondary

Measure	Time frame
Renal function tests	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient information Manager

elsayedamr@yahoo.com002-01223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026